P Cimflova1,2, R McDonough3,4, M Kappelhof3,5, N Singh1, N Kashani3, J M Ospel6, A M Demchuk1,7, B K Menon1, M Chen8, N Sakai9, J Fiehler4, M Goyal10,3. 1. From the Departments of Clinical Neurosciences (P.C., N.S., A.M.D., B.K.M., M.G.). 2. Department of Medical Imaging (P.C.), St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. 3. Diagnostic Imaging (R.M., M.K., N.K., M.G.), Foothills Medical Center, University of Calgary, Calgary, Alberta, Canada. 4. Department of Diagnostic and Interventional Neuroradiology (R.M., J.F.), University Hospital Hamburg-Eppendorf, Hamburg, Germany. 5. Department of Radiology and Nuclear Medicine (M.K.), University of Amsterdam, Amsterdam, the Netherlands. 6. Division of Neuroradiology (J.M.O.), Clinic of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland. 7. Hotchkiss Brain Institute (A.M.D.), Cumming School of Medicine, University of Calgary, Canada. 8. Department of Neurological Sciences (M.C.), Rush University Medical Center, Chicago, Illinois. 9. Department of Neurosurgery (N.S.), Kobe City Medical Centre General Hospital, Kobe, Japan. 10. From the Departments of Clinical Neurosciences (P.C., N.S., A.M.D., B.K.M., M.G.) mgoyal@ucalgary.ca.
Abstract
BACKGROUND AND PURPOSE: Thrombus embolization during mechanical thrombectomy occurs in up to 9% of cases, making secondary medium vessel occlusions of particular interest to neurointerventionalists. We sought to gain insight into the current endovascular treatment approaches for secondary medium vessel occlusion stroke in an international case-based survey because there are currently no clear recommendations for endovascular treatment in these patients. MATERIALS AND METHODS: Survey participants were presented with 3 cases involving secondary medium vessel occlusions, each consisting of 3 case vignettes with changes in the patient's neurologic status (improvement, no change, unable to assess). Multivariable logistic regression analyses clustered by the respondent's identity were used to assess factors influencing the decision to treat. RESULTS: In total, 366 physicians (56 women, 308 men, 2 undisclosed) from 44 countries provided 3294 responses to 9 scenarios. Most (54.1%, 1782/3294) were in favor of endovascular treatment. Participants were more likely to treat occlusions in the anterior M2/3 (74.3%; risk ratio = 2.62; 95% CI, 2.27-3.03) or A3 (59.7%; risk ratio = 2.11; 95% CI, 1.83-2.42) segment compared with the M3/4 segment (28.3%; reference). Physicians were less likely to pursue endovascular treatment in patients who showed neurologic improvement than in patients with an unchanged neurologic deficit (49.9% versus 57.0% responses in favor of endovascular treatment, respectively; risk ratio = 0.88, 95% CI, 0.83-0.92). Interventionalists and more experienced physicians were more likely to treat secondary medium vessel occlusions. CONCLUSIONS: Physicians' willingness to treat secondary medium vessel occlusions endovascularly is limited and varies per occlusion location and change in neurologic status. More evidence on the safety and efficacy of endovascular treatment for secondary medium vessel occlusion stroke is needed.
BACKGROUND AND PURPOSE: Thrombus embolization during mechanical thrombectomy occurs in up to 9% of cases, making secondary medium vessel occlusions of particular interest to neurointerventionalists. We sought to gain insight into the current endovascular treatment approaches for secondary medium vessel occlusion stroke in an international case-based survey because there are currently no clear recommendations for endovascular treatment in these patients. MATERIALS AND METHODS: Survey participants were presented with 3 cases involving secondary medium vessel occlusions, each consisting of 3 case vignettes with changes in the patient's neurologic status (improvement, no change, unable to assess). Multivariable logistic regression analyses clustered by the respondent's identity were used to assess factors influencing the decision to treat. RESULTS: In total, 366 physicians (56 women, 308 men, 2 undisclosed) from 44 countries provided 3294 responses to 9 scenarios. Most (54.1%, 1782/3294) were in favor of endovascular treatment. Participants were more likely to treat occlusions in the anterior M2/3 (74.3%; risk ratio = 2.62; 95% CI, 2.27-3.03) or A3 (59.7%; risk ratio = 2.11; 95% CI, 1.83-2.42) segment compared with the M3/4 segment (28.3%; reference). Physicians were less likely to pursue endovascular treatment in patients who showed neurologic improvement than in patients with an unchanged neurologic deficit (49.9% versus 57.0% responses in favor of endovascular treatment, respectively; risk ratio = 0.88, 95% CI, 0.83-0.92). Interventionalists and more experienced physicians were more likely to treat secondary medium vessel occlusions. CONCLUSIONS: Physicians' willingness to treat secondary medium vessel occlusions endovascularly is limited and varies per occlusion location and change in neurologic status. More evidence on the safety and efficacy of endovascular treatment for secondary medium vessel occlusion stroke is needed.
Authors: Carlos Pérez-García; Santiago Rosati; Carlos Gómez-Escalonilla; Alfonso López-Frías; Juan Arrazola; Manuel Moreu Journal: J Neurointerv Surg Date: 2020-12-28 Impact factor: 5.836
Authors: Johanna M Ospel; Bijoy K Menon; Andrew M Demchuk; Mohammed A Almekhlafi; Nima Kashani; Arnuv Mayank; Enrico Fainardi; Marta Rubiera; Alexander Khaw; Jai J Shankar; Dar Dowlatshahi; Josep Puig; Sung-Il Sohn; Seong H Ahn; Alexandre Poppe; Ana Calleja; Michael D Hill; Mayank Goyal Journal: Stroke Date: 2020-10-19 Impact factor: 7.914
Authors: Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin Journal: Lancet Date: 2016-02-18 Impact factor: 79.321
Authors: Jeffrey M Katz; Abdullah M Hakoun; Amir R Dehdashti; Alex B Chebl; Vikram Janardhan; Vallabh Janardhan Journal: Interv Neurol Date: 2019-08-05
Authors: Heitor C Alves; Kilian M Treurniet; Ivo G H Jansen; Albert J Yoo; Bruna G Dutra; Guang Zhang; Lonneke Yo; Adriaan C G M van Es; Bart J Emmer; René van den Berg; Ido R van den Wijngaard; Geert J Lycklama À Nijeholt; Jan-Albert Vos; Yvo B W E M Roos; Wouter Schonewille; Henk A Marquering; Charles B L M Majoie Journal: Stroke Date: 2019-10-10 Impact factor: 7.914
Authors: Reza Rikhtegar; Pascal John Mosimann; Ralph Weber; Marta Wallocha; Elif Yamac; Mohammad Mirza-Aghazadeh-Attari; René Chapot Journal: J Neurointerv Surg Date: 2021-01-19 Impact factor: 5.836